The Company:
DiFUSION Technologies, Inc. is a medical device company headquartered in Austin, Texas targeting the orthopedic market to reduce the rising incidence of Surgical Site Infections (SSIs) in spinal surgeries.
DiFUSION Technologies, Inc. is a medical device company headquartered in Austin, Texas targeting the orthopedic market to reduce the rising incidence of Surgical Site Infections (SSIs) in spinal surgeries.
Founded:
The Company was founded in 2006 by Dr. Matthew Geck and incorporated in 2008 as DiFUSION Technologies, Inc. Scientific board members comprise a team of recognized physicians in the field of spinal, biochemical and genetic research. The management team consists of senior executives possessing extensive experience in spinal product development and clinical studies.
Funding:
The company is funded by angel investors and will be seeking a second round of funding for marketing and sales support in order to roll out its medical device on a nationwide basis. Current investors are expected to participate in the upcoming round.
Market:
SSIs are a common complication surgeons confront in orthopedic surgery, with an estimated 780,000 post-operative infections occurring in the United States each year.
Antibiotic-resistant bacteria such as MRSA (also known as "Superbugs") have been a growing concern with a rising incidence of both hospital and community acquired MRSA infections. Post-operative spine infections have been reported in large studies to range in incidence from 2.5% to 13%, costing the health care industry an estimated $150 million dollars a year.
SSIs have been a focal point for quality improvement as part of the "pay for performance" initiative for both hospitals and physicians. There is a growing mandate in the medical and healthcare communities to develop protocols to minimize or eliminate SSIs within hospitals, such as the Ascension Heath Surgical Care Improvement Project.